Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial F-type ATP synthase, also known as F1F0-ATPase, is a complex, multi-subunit enzyme essential for the survival of bacteria by serving as the primary source of cellular energy (1.1.1, 1.3.2). It operates as a rotary motor that couples the movement of protons across the bacterial plasma membrane to the synthesis of adenosine triphosphate (ATP) from ADP and inorganic phosphate (1.3.1, 1.5.2). In many pathogenic species, such as Mycobacterium tuberculosis, the enzyme is critical for maintaining energy homeostasis in both actively growing and dormant states (1.2.2, 1.5.1). Therapeutic agents like bedaquiline target this enzyme with high specificity, binding to the c-ring or the epsilon subunit to stall the rotation required for ATP production (1.2.1, 1.2.4). This inhibition results in rapid ATP depletion and bacterial death, making it a validated target for treating multidrug-resistant tuberculosis (1.1.2, 1.5.5). A significant challenge in drug development is ensuring high selectivity for the bacterial enzyme over the structurally similar human mitochondrial F-ATPase to minimize host toxicity (1.1.5, 1.3.2).
Inhibition of the rotary mechanism of the F-type ATP synthase by binding to the c-ring (stalling rotation) or the epsilon subunit (disrupting coupling), which prevents ATP synthesis and leads to the depletion of cellular energy stores.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial F-type ATP synthase (F-ATPase).